Ansell (FRA:PD1) Beneish M-Score: -2.36 (As of Jun. 25, 2026)


FRA:PD1 Ansell Ltd FRA:PD1
74 GF Score
Price €68.50
GF Value €64.70
! 4 Warning Signs
View Full Analysis

What is Ansell Beneish M-Score?

Ansell FRA:PD1 +3.01% 74 Beneish M-Score is -2.36 as of Jun. 25, 2026. GuruFocus rates FRA:PD1 with a GF Score™ of 74/100 and a GF Value™ of €64.70. The stock has 4 warning signs investors should review. Among 766 Medical Devices & Instruments companies, Ansell ranks worse than 67.1% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.36 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Ansell's Beneish M-Score or its related term are showing as below:

FRA:PD1' s Beneish M-Score Range Over the Past 10 Years
Min: -2.99   Med: -2.58   Max: -1.66
Current: -2.36

During the past 13 years, the highest Beneish M-Score of Ansell was -1.66. The lowest was -2.99. And the median was -2.58.


Ansell Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Ansell's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ansell Beneish M-Score Chart

Ansell Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.01 -2.59 -2.56 -2.87 -2.36

Ansell Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -2.87 0.00 -2.36 0.00

FRA:PD1 vs ISRG, BDX, MDLN: Beneish M-Score Comparison

For the Medical Instruments & Supplies subindustry, Ansell's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ansell Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ansell's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Ansell's Beneish M-Score falls into.


FRA:PD1
74GF Score
Ansell Ltd FRA:PD1
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ansell Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Ansell for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9403+0.528 * 0.9369+0.404 * 1.432+0.892 * 1.1546+0.115 * 1.0514
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0458+4.679 * -0.041446-0.327 * 1.0113
=-2.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun25) TTM:Last Year (Jun24) TTM:
Total Receivables was €214 Mil.
Revenue was €1,737 Mil.
Gross Profit was €715 Mil.
Total Current Assets was €963 Mil.
Total Assets was €2,881 Mil.
Property, Plant and Equipment(Net PPE) was €412 Mil.
Depreciation, Depletion and Amortization(DDA) was €65 Mil.
Selling, General, & Admin. Expense(SGA) was €556 Mil.
Total Current Liabilities was €453 Mil.
Long-Term Debt & Capital Lease Obligation was €628 Mil.
Net Income was €88 Mil.
Gross Profit was €0 Mil.
Cash Flow from Operations was €207 Mil.
Total Receivables was €197 Mil.
Revenue was €1,504 Mil.
Gross Profit was €580 Mil.
Total Current Assets was €1,509 Mil.
Total Assets was €3,012 Mil.
Property, Plant and Equipment(Net PPE) was €405 Mil.
Depreciation, Depletion and Amortization(DDA) was €67 Mil.
Selling, General, & Admin. Expense(SGA) was €460 Mil.
Total Current Liabilities was €393 Mil.
Long-Term Debt & Capital Lease Obligation was €724 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(213.715 / 1736.861) / (196.855 / 1504.33)
=0.123047 / 0.130859
=0.9403

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(580.439 / 1504.33) / (715.275 / 1736.861)
=0.385846 / 0.411821
=0.9369

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (963.064 + 412.345) / 2880.521) / (1 - (1508.603 + 404.58) / 3012.375)
=0.522514 / 0.364892
=1.432

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1736.861 / 1504.33
=1.1546

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(67.445 / (67.445 + 404.58)) / (64.852 / (64.852 + 412.345))
=0.142884 / 0.135902
=1.0514

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(555.834 / 1736.861) / (460.32 / 1504.33)
=0.320022 / 0.305997
=1.0458

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((628.228 + 452.574) / 2880.521) / ((724.341 + 393.339) / 3012.375)
=0.375211 / 0.37103
=1.0113

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(88.087 - 0 - 207.473) / 2880.521
=-0.041446

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Ansell has a M-score of -2.46 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.36 mean?
Ansell (FRA:PD1) has a Beneish M-Score of -2.36 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Ansell and its competitors. According to the industry distribution chart, Ansell ranks #514 out of 766 companies in the Medical Devices & Instruments industry, placing it in the top 67.1%.
Is Ansell's Beneish M-Score too high?
Ansell's current Beneish M-Score is -2.36. Based on the distribution chart, Ansell ranks #514 out of 766 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Ansell has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Ansell's Beneish M-Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ansell ranks #514 out of 766 companies for Beneish M-Score. This places Ansell in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Ansell and its competitors. Ansell's current Beneish M-Score is -2.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ansell stock overvalued right now?
Ansell (FRA:PD1) has a current Beneish M-Score of -2.36. The stock's GF Value™ is €64.70, compared to a current price of €68.50 — trading 5.9% above its estimated fair value. The current Beneish M-Score is -2.36. Ansell's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Ansell (FRA:PD1), the current Beneish M-Score is -2.36 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ansell (FRA:PD1) Overvalued in 2026?

Based on GuruFocus' analysis, Ansell stock appears to be overvalued. The current stock price of €68.50 is trading 5.9% above its estimated GF Value™ of €64.70.

Key valuation signals for FRA:PD1:

  • Beneish M-Score: -2.36
  • GF Value™: €64.70 vs. price of €68.50 (5.9% above fair value)
  • GF Score™: 74/100 with 4 warning signs

No single metric tells the full story. See the FRA:PD1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ansell Business Description

Address 678 Victoria Street, Level 3, Richmond, Melbourne, VIC, AUS, 3121
Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 55% of revenue and operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents, and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly. Largest sales regions are North America and Europe, Middle East, and Africa. Asia-Pacific and Latin America, combined, are about one-fourth of sales.
74GF Score

Get the complete analysis for FRA:PD1

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€68.50
Price
€64.70
GF Value